PFN1
PFN1 (profilin 1) is a small actin-binding protein of the profilin family that regulates actin polymerisation and so shapes the structure of the cytoskeleton. It acts in response to extracellular signals and also binds PIP2. Browse Assay Genie's current range of PFN1 research reagents below, or read on for the biology behind the target.
PFN1 binds actin and affects the structure of the cytoskeleton. Its effect on actin depends on concentration: at high concentrations profilin prevents actin polymerisation, whereas at low concentrations it enhances it. Through this activity the protein regulates actin dynamics in response to extracellular signals. PFN1 also binds PIP2, and by doing so it inhibits the formation of IP3 and DG.
The PFN1 gene encodes a member of the profilin family of small actin-binding proteins, and the encoded protein is localised to the cytoplasm and cytoskeleton. HGNC places it in the Profilins gene group, alongside related genes such as PFN2, PFN3 and PFN4. Orthologous genes, named Pfn1, are found in mouse and rat, which allows the protein to be studied in common model systems. Multiple pseudogenes of the gene are located on chromosome 1.
PFN1 has been linked to disease in several ways. Deletion of the gene is associated with Miller-Dieker syndrome, and the protein may also play a role in Huntington disease. UniProt annotation records that PFN1 inhibits aggregation of the androgen receptor (AR) and of HTT, and that binding of G-actin is essential for its inhibition of AR. These properties make the PFN1 protein relevant to studies of both cytoskeletal biology and protein aggregation.
PFN1 regulates actin polymerisation in a concentration-dependent manner, making it a central protein for studying cytoskeletal organisation.
The protein regulates actin polymerisation in response to extracellular signals, linking external cues to cytoskeletal change.
PFN1 may play a role in Huntington disease and inhibits HTT aggregation, a focus for aggregation research.
By binding PIP2, PFN1 inhibits the formation of IP3 and DG, connecting the cytoskeleton to lipid signalling.
PFN1 binds actin and affects cytoskeletal structure. At high concentrations it prevents actin polymerisation, while at low concentrations it enhances it. It also binds PIP2, thereby inhibiting formation of IP3 and DG, and it inhibits aggregation of the androgen receptor and HTT.
PFN1 is profilin 1, a member of the profilin family and of the HGNC Profilins gene group. Related family members include PFN2, PFN3 and PFN4. The HGNC symbol PFN1 is the standard name, and no alternative aliases or previous symbols are listed.
Mouse and rat both have a Pfn1 ortholog, so the protein can be studied in rodent models; check the datasheet of any product for its validated reactivity. Deletion of the human gene is associated with Miller-Dieker syndrome, and PFN1 may play a role in Huntington disease.
Other members of the profilin family, which share actin-binding activity with PFN1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P07737; product specifications from Assay Genie datasheets.